David Edwards and Jesper Madsen Novo Nordisk

Slides:



Advertisements
Similar presentations
Gatekeeping Testing Strategies in Clinical Trials Alex Dmitrienko, Ph.D. Eli Lilly and Company FDA/Industry Statistics Workshop September 2004.
Advertisements

Issues of Simultaneous Tests for Non-Inferiority and Superiority Tie-Hua Ng*, Ph. D. U.S. Food and Drug Administration Presented at MCP.
Presented By Martine Piccart-Gebhart at 2014 ASCO Annual Meeting
A Flexible Two Stage Design in Active Control Non-inferiority Trials Gang Chen, Yong-Cheng Wang, and George Chi † Division of Biometrics I, CDER, FDA Qing.
Role of Pharmaceutical Statistician March 10, 2009 The Role of the Pharmaceutical Statistician What can be improved? Per Larsson Head of Biostatistics.
1 O Guilbaud, MCP2007, July 8-11, Vienna, v.1 Simultaneous Confidence Regions corresponding to Holm’s Step-down MTP (and other CTPs) Olivier Guilbaud.
The equivalence trial Didier Concordet NATIONAL VETERINARY S C H O O L T O U L O U S E.
Statistics 101 Class 8. Overview Hypothesis Testing Hypothesis Testing Stating the Research Question Stating the Research Question –Null Hypothesis –Alternative.
(CSC 102) Discrete Structures Lecture 14.
By Trusha Patel and Sirisha Davuluri. “An efficient method for accommodating potentially underpowered primary endpoints” ◦ By Jianjun (David) Li and Devan.
A new group-sequential phase II/III clinical trial design Nigel Stallard and Tim Friede Warwick Medical School, University of Warwick, UK
Topic 6: Introduction to Hypothesis Testing
SMART Designs for Developing Adaptive Treatment Strategies S.A. Murphy K. Lynch, J. McKay, D. Oslin & T.Ten Have CPDD June, 2005.
Discrete Mathematics Lecture#11.
Adaptive Designs for Clinical Trials
Induction and recursion
Proprietary and Confidential © AstraZeneca 2009 FOR INTERNAL USE ONLY 1 O Guilbaud, FMS+Cramér Society, AZ-Södertälje, Alpha Recycling in Confirmatory.
Solving fixpoint equations
Challenges of Non-Inferiority Trial Designs R. Sridhara, Ph.D.
Faculty Research Interest Seminar Series Graduate School of Public Health, UNIVERSITY of PITTSBURGH Methodological Research and Collaboration Lan Kong.
Decision-Theoretic Views on Switching Between Superiority and Non-Inferiority Testing. Peter Westfall Director, Center for Advanced Analytics and Business.
Copyright © Cengage Learning. All rights reserved. CHAPTER 7 FUNCTIONS.
1 Statistics in Drug Development Mark Rothmann, Ph. D.* Division of Biometrics I Food and Drug Administration * The views expressed here are those of the.
All-or-None procedure: An outline Nanayaw Gyadu-Ankama Shoubhik Mondal Steven Cheng.
DSBS Discussion: Multiple Testing 28 May 2009 Discussion on Multiple Testing Prepared and presented by Lars Endahl.
1 Controlling False Positive Rate Due to Multiple Analyses Controlling False Positive Rate Due to Multiple Analyses Unstratified vs. Stratified Logrank.
The Use of Predictive Biomarkers in Clinical Trial Design Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute
Fall 2015 COMP 2300 Discrete Structures for Computation Donghyun (David) Kim Department of Mathematics and Physics North Carolina Central University 1.
Not in FPP Bayesian Statistics. The Frequentist paradigm Defines probability as a long-run frequency independent, identical trials Looks at parameters.
Power & Sample Size Dr. Andrea Benedetti. Plan  Review of hypothesis testing  Power and sample size Basic concepts Formulae for common study designs.
Section 4.4 Properties of Relations. Order Relations Draw an arrow diagram for the relation R defined on the set {1,2,3,4} such that
Inen 460 Lecture 2. Estimation (ch. 6,7) and Hypothesis Testing (ch.8) Two Important Aspects of Statistical Inference Point Estimation – Estimate an unknown.
Equivalence Relations. Partial Ordering Relations 1.
MPS/MSc in StatisticsAdaptive & Bayesian - Lect 51 Lecture 5 Adaptive designs 5.1Introduction 5.2Fisher’s combination method 5.3The inverse normal method.
Chapter 8: Relations. 8.1 Relations and Their Properties Binary relations: Let A and B be any two sets. A binary relation R from A to B, written R : A.
Mathematical Induction Section 5.1. Climbing an Infinite Ladder Suppose we have an infinite ladder: 1.We can reach the first rung of the ladder. 2.If.
Relations and Functions ORDERED PAIRS AND CARTESIAN PRODUCT An ordered pair consists of two elements, say a and b, in which one of them, say a is designated.
1 Chapter 4 Generating Permutations and Combinations.
SMART Trials for Developing Adaptive Treatment Strategies S.A. Murphy Workshop on Adaptive Treatment Designs NCDEU, 2006.
A Parametrized Strategy of Gatekeeping, Keeping Untouched the Probability of Having at Least One Significant Result Analysis of Primary and Secondary Endpoints.
Remaining Challenges in Assessing Non-Inferiority Steven Snapinn DIA Statistics Community Virtual Journal Club December 16, 2014 Based on Paper with Qi.
Module Code MA1032N: Logic Lecture for Week Autumn.
Dilworth’s theorem and extremal set theory 張雁婷 國立交通大學應用數學系.
Relations and Their Properties
Comparing Multiple Factors:
CHAPTER 10 Comparing Two Populations or Groups
Comparing Three or More Means
6.1 One-to-One Functions; Inverse Function
Chapter 10: Analysis of Variance: Comparing More Than Two Means
Chapter 8: Inference for Proportions
CHAPTER 10 Comparing Two Populations or Groups
Multiple Endpoint Testing in Clinical Trials – Some Issues & Considerations Mohammad Huque, Ph.D. Division of Biometrics III/Office of Biostatistics/OPaSS/CDER/FDA.
Strategies for Implementing Flexible Clinical Trials Jerald S. Schindler, Dr.P.H. Cytel Pharmaceutical Research Services 2006 FDA/Industry Statistics Workshop.
3.3 Applications of Maximum Flow and Minimum Cut
Multiplicity Testing Procedure Selection in Clinical Trials Rachael Wen Ph.D JSM 2018 of 8.
4.1 One-to-One Functions; Inverse Function
CHAPTER 10 Comparing Two Populations or Groups
6.1 One-to-One Functions; Inverse Function
CHAPTER 10 Comparing Two Populations or Groups
CHAPTER 10 Comparing Two Populations or Groups
Advanced Analysis of Algorithms
Covering Principle to Address Multiplicity in Hypothesis Testing
CHAPTER 10 Comparing Two Populations or Groups
CHAPTER 10 Comparing Two Populations or Groups
CHAPTER 10 Comparing Two Populations or Groups
DAGs Longin Jan Latecki
Medical Statistics Exam Technique and Coaching, Part 2 Richard Kay Statistical Consultant RK Statistics Ltd 22/09/2019.
Incorporating the sample correlation between two test statistics to adjust the critical points for the control of type-1 error Dror Rom and Jaclyn McTague.
Presentation transcript:

David Edwards and Jesper Madsen Novo Nordisk Sequentially rejective test procedures for partially ordered sets of hypotheses David Edwards and Jesper Madsen Novo Nordisk Or: a way to construct inference strategies for clinical trials that closely reflect the trial objectives and strongly control the FWE.

Outline Motivating example Some theory Examples Summary Partially closed test procedures 14 May 2019 Outline Motivating example Some theory Examples Summary

Partially closed test procedures 14 May 2019 Motivating Example Consider a three-arm trial, comparing a high and a low dose of an experimental drug with an active control. The goal is to demonstrate non-inferiority and, if possible, superiority of each dose to the active control. There are four null hypotheses: inferiority of high dose inferiority of low dose non-superiority of high dose non-superiority of low dose

Motivating Example We could consider Partially closed test procedures 14 May 2019 Motivating Example We could consider Test inferiority of high dose if rejected Test non-superiority of high dose Test inferiority of low dose if rejected Test non-superiority of low dose This gives strong FWE control for each dose, but not overall.

Motivating Example… Or we could consider Partially closed test procedures 14 May 2019 Motivating Example… Or we could consider Test inferiority for high dose if rejected Test inferiority for low dose Test non-superiority for high dose if rejected Test non-superiority for low dose Again, this does not give overall FWE control

Partially closed test procedures 14 May 2019 Motivating Example… But what about a ’two-dimensional’ sequentially rejective procedure? Test inferiority for high dose Test non-superiority for high dose if rejected if both rejected if rejected Test inferiority for low dose Test non-superiority for low dose Does this control the FWE?

Partially closed test procedures 14 May 2019 Some theory… Let F = {H1, .. HK} be a partially ordered set of null hypotheses. A partial ordering  (precedes) is a binary relation that is irreflexive and transitive, that is, no element precedes itself, and v  w and w  x  v  x. We draw F as a directed acyclic graph (DAG): draw an arrow from v to w whenever v  w, but there is no element x with v  x  w. We consider sequentially rejective procedures on F: ie each hypothesis is tested using an -level test if and only if all preceding hypotheses have been tested and rejected at the  level.

Partially closed test procedures 14 May 2019 Some theory… A subset of a partially ordered set is called an antichain if no element of the subset precedes any other element of the subset. Consider the antichains of F with  2 elements. Let I={I1, … It} be the corresponding intersection hypotheses. The p-closed version of F is defined as F*=F  I endowed with the natural partial ordering (see paper). Theorem: A sequentially rejective procedure on F* strongly controls the FWE with respect to F.

Applied to the ’motivating example’ Partially closed test procedures 14 May 2019 Applied to the ’motivating example’ so 1 intersection hypothesis is inserted There is 1 antichain with  2 elements

Example: gold standard design Partially closed test procedures 14 May 2019 Example: gold standard design Comparing experimental treatment with placebo and an active control inferiority to control non-superiority to control non-superiority to placebo

Example: gold standard design with 2 doses Partially closed test procedures 14 May 2019 Example: gold standard design with 2 doses Now suppose there are two doses of the experimental drug. We would like an inference strategy like:

Example: gold standard design with two doses Partially closed test procedures 14 May 2019 Example: gold standard design with two doses For FWE control we insert 3 intersection hypotheses:

Non-inferiority/superiority for two endpoints Partially closed test procedures 14 May 2019 Non-inferiority/superiority for two endpoints Two co-primary endpoints X and Y. The goal is to show that the experimental treatment is non-inferior (and if possible superior) to the control for both X and Y. Null hypotheses: H1: inferior wrt X H2: non-superior wrt X H3: inferior wrt Y H4: non-superior wrt Y Since (H1  H3)c = H1c  H3c we must first test H1  H3

Non-inferiority/superiority for two endpoints Partially closed test procedures 14 May 2019 Non-inferiority/superiority for two endpoints

Closed test procedures are a special case Partially closed test procedures 14 May 2019 Closed test procedures are a special case

Serial gatekeeper procedures are a special case Partially closed test procedures 14 May 2019 Serial gatekeeper procedures are a special case

A ’modified’ serial gatekeeping procedure Partially closed test procedures 14 May 2019 A ’modified’ serial gatekeeping procedure Omit arrow from 1 to 6 Entanglement: 1 & 6 precedes 1

Partially closed test procedures 14 May 2019 Summary We have shown how to construct multiple test procedures that strongly control the FWE, which are closely tailored to the study objectives, are transparent and easily understood by non-statisticians, and include as special cases: closed test procedures, hierarchical (fixed sequence) test procedures, and serial gatekeeping procedures.

Partially closed test procedures 14 May 2019 Reference Edwards, D and Madsen, J. Constructing multiple test procedures for partially ordered hypothesis sets, Statistics in Medicine, to appear.